Mycobacterium tuberculosis Modulates the Expansion of Terminally Exhausted CD4+ and CD8+ T-Cells in Individuals with HIV-TB Co-Infection
Pathogens · 2025
DOI: 10.3390/pathogens14080802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Komal Sharma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Immunology Laboratory, Department of Immunopathology, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh 160012, …. Hauptthemen laut MEDLINE: HIV Infections, Coinfection, CD8-Positive T-Lymphocytes, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anusandhan National Research foundation (ANRF), Science and Engineering Research Board (SERB), Department of Science and Technology (DST).
Abstract (Originalsprache)
Introduction
Mycobacterium tuberculosis (Mtb), the most common co-infection among people living with HIV (PLWH), aggravates the associated morbidity and mortality in these individuals; however, the immune-modulatory role of Mtb in the pathogenesis of HIV infection remains incompletely understood.
Methods
We investigated the role of Mtb infection in regulating adaptive immune responses with reference to the expression of five immune checkpoint molecules (ICMs) in co-infected individuals in a cross-sectional study conducted on treatment-naïve human cohorts from North India, including PLWH, people with Mtb infection, people with HIV-Mtb co-infection, and healthy volunteers as controls.
Results
The data revealed a significantly increased gene expression of TIM-3 (p = 0.0058), LAG-3 (p < 0.0001), PD-1 (p = 0.0090), and CTLA-4 (p = 0.0008). It also revealed a higher frequency of CD4+ and CD8+ T-cells surface-expressing TIM-3+, CTLA-4+, LAG-3+. Finally, it showed cells co-expressing two ICMs together (p < 0.05) in individuals with HIV–Mtb co-infection as compared to HIV mono-infected ones. Interestingly, the frequency of these cells correlated inversely with the absolute CD4+ T-cell count and positively with the plasma viral load (p < 0.05), indicating direct association with HIV disease progression.
Conclusions
These findings suggest that Mtb co-infection exacerbates immune exhaustion in co-infected individuals. Targeting ICMs with pharmacological immune checkpoint inhibitors (ICIs) offers a promising approach for better clinical management of co-infected individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Immunology Laboratory, Department of Immunopathology, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh 160012, India.
- Department of Internal Medicine, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh 160012, India.
ORCID-Profile: Komal Sharma, Sunil K Arora
Förderung
- Anusandhan National Research foundation (ANRF)
- Science and Engineering Research Board (SERB)
- Department of Science and Technology (DST)
- Government of India
- Indian Council of Medical Research (ICMR), Government of India, New Delhi
- Anusandhan National Research foundation (ANRF), Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India
Zitieren
APA
Sharma, K., Sharma, A., & Arora, S. K. (2025). Mycobacterium tuberculosis Modulates the Expansion of Terminally Exhausted CD4+ and CD8+ T-Cells in Individuals with HIV-TB Co-Infection. Pathogens. https://doi.org/10.3390/pathogens14080802
Vancouver
Sharma K, Sharma A, Arora SK. Mycobacterium tuberculosis Modulates the Expansion of Terminally Exhausted CD4+ and CD8+ T-Cells in Individuals with HIV-TB Co-Infection. Pathogens. 2025. doi:10.3390/pathogens14080802
BibTeX
@article{Sharma2025,
author = {Sharma, Komal and Sharma, Aman and Arora, Sunil K},
title = {Mycobacterium tuberculosis Modulates the Expansion of Terminally Exhausted CD4+ and CD8+ T-Cells in Individuals with HIV-TB Co-Infection},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14080802}
}
EUVIMED